Abstract
The ability of111In-PAY 276 (anti prostatic acid phosphatase antibody) in detecting pelvic lymph node metastasis following bipedal intra lymphatic administration was studied in five patients with carcinoma of the prostate. The labeled antibody was injected directly into the lymphatics of each foot. Planar and tomographic images radioactivity content of lymph nodes resected during staging pelvic lymphadenectomy were compared to the histologic and immunoperoxidase findings. Radioactivity in pelvic lymph nodes was prominently seen within 20 min of injection and was present 16 days later. Persistent accumulation of tracer in the lymphatics of the lower extremities was also observed in all patients 16 days post injection. Radioactivity counts in tumor-free lymph nodes were higher than in tumored lymph nodes resected. Our results demonstrate that intra lymphatic administration of111In-labeled PAY 276 monoclonal antibody has major technical limitations, and that further research directed at the causes of tracer accumulation in the lymphatics and tumor-free lymph nodes is required.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Babaian RJ, Murray JL, Lamki LM, Haynie TP, Hersh EM, Rosenblum MG, Gleen HJ, Unger MW, Carlo DJ, von Eschenbach AC (1987) Radioimmunological imaging of metastatic prostatic cancer with111 Indium-labeled monoclonal antibody PAY 276. J Urol 137:439–443
Biondetti PR, Lee JKT, Ling D, Catalona WJ (1987) Clinical stage B prostate carcinoma: Staging with MR imaging. Radiology 162:325–329
Ege GN (1982) Augmented iliopelvic lymphoscintigraphy: Application in the management of genitourinary malignancy. J Urol 127:265–269
Engelstad BL, Spitler LE, Del Rio MJ, Ramos EC, Rosendrof LL, Reinbold CE, Khentigan A, Huberty JP, Corpuz SW, Lee HM, Okerlund MD, Hattner RS, Scannon PJ (1986) Phase 1. Immunolymphoscintigraphy with an In-111-labeled antimelanoma monoclonal antibody. Radiology 161:419–422
FlaniganRC MohlerJL KingCT Atwell JR, Umer MA, Loh F, McRoberts JW (1985) Preoperative lymph node evaluation in prostate cancer patients who are surgical candidates: the role of lymphangiography and computerized tomography scanning with directed fine needle aspiration. J Urol 134:84–87
Gardiner RA, Fitzpatrick JM, Constable AR, Cranage RW, O'Donahue EP, Wickham JE (1979) Improved techniques in radionuclide imaging of prostatic lymph nodes. Brit J Urol 51:561–564
Goldenberg DM, DeLand FH, Bennett SJ, Primus FJ, Nelson MO, Flanigan RC, McRoberts JW, Bruce AW, Mahan DE (1983) Radioimmunodetection of prostatic cancer. In vivo use of radioactive antibodies against prostatic acid phosphatase for diagnosis and detection of prostatic cancer by nuclear imaging. JAMA 250:630–635
Henneberry MO, Engel G, Grayhack JT (1979) Acid phosphatase. Urol Clin North Am 6:629–641
Hricak H, Dooms GC, Jeffrey RB, Avallone A, Jacobs D, Benton WK, Narayan P, Tanagho EA (1987) Prostatic carcinoma: Staging by clinical assessment, CT, and MRI imaging. Radiology 162:331–336
Keenan AM, Weinstein JN, Mulshine JL, Carresquillo JA, Bunn PA Jr, Reynolds JC, Larson SM (1987) Immunolymphoscintigraphy in patients with lymphoma after subcutaneous injection of Indium-111-labeled T-101 monoclonal antibody. J Nucl Med 28:42–46
Mukamel E, Hannah J, Babaric Z, deKernion JB (1987) The value of computerized tomography scan and magnetic resonance imaging in staging prostatic carcinoma: Comparison of the clinical and histological staging. J Urol 136:1231–1233
Nelp WB, Eary JF, Jones RF, Hellstrom KE, Hellstrom I, Beaumier PL, Krohn KA (1987) Preliminary studies of monoclonal antibody lymphoscintigraphy in malignant melanoma. J Nucl Med 28:34–41
Nissenkorn I, Winkler H, Sevadio C, Melloul M, Lubin E, Idelsohn AR, Hadar H (1986) A comparative evaluation of lymphoscintigraphy versus lymphangiography and computerized tomography scanning in diagnosis of lymph node metastases in advanced bladder carcinoma. J Urol 136:825–827
Paul DB, Loening SA, Naryana AS, Culp DA (1983) Morbidity from pelvic lymphadenectomy in staging carcinoma of the prostate. J Urol 129:1141–1144
Schaeffer DL, Pendergrass HP (1976) Comparison of enzyme, clinical, radiographic and radionuclide methods of detecting bone metastases from carcinoma of the prostate. Radiology 121:431–434
Steller MA, Parker RJ, Covell DG, Holton OD III, Keenan AM, Sieber SM, Weinstein JN (1986) Optimization of monoclonal antibody delivery via the lymphatics: The dose dependence. Cancer Res 46:1830–1834
Vihko P, Heikkila J, Kontturi M, Wahlberg L, Vihko R (1984) Radioimmaging of the prostate and metastases of prostatic carcinoma with Tc-99m labelled prostatic acid phosphatase specific antibodies and their Fab fragments. Ann Clin Res 16:5152
Weinstein JN, Parker RJ, Holton OD III, Keenan AM, Covell DG, Black CDV, Sieber SM (1985) Lymphatic delivery of monoclonal antibodies: Potential for detection and treatment of lymph node metastases. Cancer Invest 3:85–95
Weinstein JN, Parker RJ, Keenan AM, Dower SK, Morse HC III, Sieber SM (1982) Monoclonal antibodies in the lymphatics: Toward the diagnosis and therapy of tumor metastases. Science (Wash. D.C.), 218:1334–1337
Whitmore WF III, Blute RD Jr, Kaplan WD, Gittes RF (1980) Radiocolloid scintigraphic mapping of the lymphatic drainage of the prostate. J Urol 124:62–67
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Abdel-Nabi, H.H., Ortman-Nabi, J.A., See, W. et al. Clinical experience with intra lymphatic administration of111In-labelled monoclonal antibody PAY 276 for the detection of pelvic nodal metastases in prostatic carcinoma. Eur J Nucl Med 16, 149–156 (1990). https://doi.org/10.1007/BF01146853
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF01146853